PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-May-2022 908 Devices Partners with Key Biomanufacturing Innovation Center Businesswire
03-May-2022 Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 Pfizer Reports First-Quarter 2022 Results Businesswire
03-May-2022 Japan In-Vitro Diagnostics (IVD) Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-May-2022 International Pregistry Study Examines Treatments Used for COVID-19 During Pregnancy Businesswire
03-May-2022 Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer Businesswire
03-May-2022 End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting Businesswire
03-May-2022 Asia Breast Cancer Screening Market Research Report 2022: Size, Forecasts, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis 2021-2027 - ResearchAndMarkets.com Businesswire
03-May-2022 NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer Businesswire
03-May-2022 Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies Businesswire
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder Idorsia
03-May-2022 Ipsen : La Commission européenne approuve Cabometyx® comme traitement de deuxième ligne dans le cancer de la thyroïde différencié réfractaire à l’iode radioactif Businesswire
03-May-2022 Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer Businesswire
03-May-2022 Deenova Launches First Ever, Pay-Per-Dose Unit Dose Pharmacy Automation Service in England Businesswire
03-May-2022 EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA Editing Efficiency and Outcomes for Therapeutic Development at the ASGCT 25th Annual Meeting Businesswire
03-May-2022 Jaguar Gene Therapy Announces Preclinical Data Presentations at Upcoming American Society of Gene and Cell Therapy 25th Annual Meeting Businesswire
02-May-2022 Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Society of Gene & Cell Therapy 25th Annual Meeting Businesswire
02-May-2022 Stoke Therapeutics Presents New In-Vivo Data That Demonstrated Dose-Related Target Engagement and OPA1 Protein Upregulation in Retinal Tissue Following Administration of STK-002 Businesswire
02-May-2022 Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Solid Tumors Businesswire